35.94
Precedente Chiudi:
$35.39
Aprire:
$35.45
Volume 24 ore:
85,663
Relative Volume:
0.19
Capitalizzazione di mercato:
$1.64B
Reddito:
$1.23B
Utile/perdita netta:
$20.43M
Rapporto P/E:
81.48
EPS:
0.4411
Flusso di cassa netto:
$95.39M
1 W Prestazione:
+3.19%
1M Prestazione:
+10.14%
6M Prestazione:
-4.24%
1 anno Prestazione:
+20.12%
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, TEM, BTSG, HNGE, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OMCL
Omnicell Inc
|
35.94 | 1.64B | 1.23B | 20.43M | 95.39M | 0.4411 |
|
VEEV
Veeva Systems Inc
|
312.61 | 50.61B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
68.94 | 12.52B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.49 | 12.37B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.39 | 8.50B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.81 | 7.68B | 1.34B | 230.70M | 440.96M | 2.6695 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Is This the Right Time to Retain Omnicell Stock in Your Portfolio? - TradingView
Omnicell, Inc. (OMCL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) stock price, news, quote and history - Yahoo Finance UK
Omnicell, Inc. (OMCL) stock price, news, quote and history - Yahoo Finance Singapore
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo! Finance Canada
Press Release: Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 - Moomoo
Omnicell to Release Third Quarter 2026 Financial Results on October 29, 2026 - Business Wire
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Does Omnicell’s Revenue Beat and Weak EBITDA Guidance Change The Bull Case For OMCL? - Yahoo Finance
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL) - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Cost of goods sold of Omnicell, Inc. – HAN:OC9 - TradingView
Omnicell, Inc. Bonds — Corporate Bond Rates - TradingView
EBIT per share of Omnicell, Inc. – HAN:OC9 - TradingView
ETFs Investing in Omnicell, Inc. Stocks - TradingView
Omnicell (NasdaqGS:OMCL) Stock Forecast & Analyst Predictions - Simply Wall Street
Omnicell stock trades 39.95 percent below its yearly high - AD HOC NEWS
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Omnicell Inc (OC9.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell, Inc. (OMCL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Omnicell (OMCL) Stock Trades Below Fair Value After A 78% Slump - Yahoo Finance
3 Reasons OMCL is Risky and 1 Stock to Buy Instead - Yahoo Finance
Omnicell, Inc. (OMCL) Stock Forecasts - Yahoo Finance
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Is Omnicell Inc (OMCL) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com Canada
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com India
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle - Investing.com
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com UK
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations - marketscreener.com
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - The Malaysian Reserve
Craig-Hallum Maintains Omnicell(OMCL.US) With Buy Rating - Moomoo
A new integration lets hospitals check medicines as they arrive - Stock Titan
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - PR Newswire
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Omnicell Inc (OMCL) Stock Up 6.3% and Still Undervalued -- GF Sc - GuruFocus
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference - Yahoo Finance
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
Omnicell Stock Price Forecast. Should You Buy OMCL? - StockInvest.us
Omnicell Inc. ($0.001 par value) (OMCL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
KeyBanc reiterates Omnicell stock rating on large pipeline growth By Investing.com - Investing.com Canada
KeyBanc reiterates Omnicell stock rating on large pipeline growth - Investing.com
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omnicell Inc Azioni (OMCL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Njoku Nnamdi | Officer |
Aug 17 '26 |
Proposed Sale |
36.85 |
3,083 |
113,609 |
0 |
| LIPPS RANDALL A | CHAIRMAN, CEO |
Jul 15 '26 |
Sale |
47.00 |
10,000 |
470,000 |
345,861 |
| Randall Lipps | Officer |
Jul 15 '26 |
Proposed Sale |
47.00 |
10,000 |
470,000 |
0 |
| Njoku Nnamdi | EVP, Chief Operating Officer |
May 18 '26 |
Sale |
43.22 |
3,090 |
133,550 |
154,785 |
| Manley Corey J | Officer |
May 18 '26 |
Proposed Sale |
43.22 |
5,025 |
217,180 |
0 |
| Njoku Nnamdi | Officer |
May 18 '26 |
Proposed Sale |
43.22 |
3,090 |
133,550 |
0 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
Mar 16 '26 |
Sale |
34.69 |
7,405 |
256,879 |
96,717 |
| Manley Corey J | Officer |
Mar 16 '26 |
Proposed Sale |
34.69 |
7,405 |
256,879 |
0 |
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
Feb 17 '26 |
Sale |
36.59 |
4,243 |
155,251 |
85,496 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):